Literature DB >> 9291937

CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

M M Ruchoux1, C A Maurage.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a recently identified cause of stroke and vascular dementia. It is a condition of mid-adulthood due to mutations of Notch 3 gene on chromosome 19. Whereas the disease was first reported in European families, since 1993 CADASIL has been observed in American, African and Asiatic pedigrees, suggesting that today, the disease probably still remains largely underdiagnosed. The pathological data first dealt with the white matter and the basal ganglia showing the features observed in Binswanger's subcortical arteriopathic encephalopathy; over the past few years, CADASIL has become appreciated as a systemic vascular disease with specific features. Here we have reviewed the literature from 1977 to the present for pathologically and genetically verified cases accompanied by relatively complete clinical descriptions so as to give the pathological features associated with this condition a clearer definition. The review will focus mainly on pathological studies and the pathophysiological mechanisms most likely to be involved in CADASIL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291937

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  34 in total

Review 1.  The neuropsychiatry of subcortical ischemic brain disease.

Authors:  D Feil; A Kumar
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Hairong Dong; Mila Blaivas; Michael M Wang
Journal:  Brain Res       Date:  2012-03-23       Impact factor: 3.252

Review 3.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

4.  Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy).

Authors:  Sumeet Singhal; Hugh S Markus
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

5.  Vascular accumulation of the small leucine-rich proteoglycan decorin in CADASIL.

Authors:  Soo Jung Lee; Xiaojie Zhang; Michael M Wang
Journal:  Neuroreport       Date:  2014-09-10       Impact factor: 1.837

6.  Novel pathological features and potential therapeutic approaches for CADASIL: insights obtained from a mouse model of CADASIL.

Authors:  Xiao-Yun Liu; Maria E Gonzalez-Toledo; Austin Fagan; Wei-Ming Duan; Yanying Liu; Siyuan Zhang; Bin Li; Chun-Shu Piao; Lila Nelson; Li-Ru Zhao
Journal:  Ther Targets Neurol Dis       Date:  2014-12-02

7.  Linking Notch signaling to ischemic stroke.

Authors:  Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

8.  Small vessel disease and subcortical vascular dementia.

Authors:  Raj N Kalaria; Timo Erkinjuntti
Journal:  J Clin Neurol       Date:  2006-03-20       Impact factor: 3.077

9.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

10.  Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Authors:  Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.